The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Lasa Supergenerics Ltd

Lasa Supergenerics Ltd

BSE 540702 · NSE LASA · ISIN INE670X01014 · Group B · Suspended

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹6.93

-1.42%

BSE close, 28 August 2026

Market cap

₹34.72 cr

5.0 cr shares · Micro cap

Free float

₹16.06 cr

as published

P/E · P/B

— · —

EPS — · BV —

FY25-26 rev / PAT

25.14 / -34.09

₹ cr, as filed

Filings, window

10

2 selected · 20%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹5.65 52-WK HIGH ₹14.14 ₹6.93 15% of range
Against 52-week high-51.0%
Against 52-week low+22.7%
Day change-1.42%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share—
Price / earnings—
Price / book—
Book value — derived, price ÷ P/B—
Return on equity-18.24%
Operating margin-144.25%
Net margin-291.69%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 1.23 -3.58 0.71 -144.25% -291.69%
Mar-26 · Q -0.13 -4.16 -0.83 — —
FY25-26 25.14 -34.09 -6.80 -112.19% -135.60%

Quarter on quarter

Revenue, quarter on quarter
+1,046.2%
Net profit, quarter on quarter
+13.9%

Disclosure profile 10 filings in the window

0 median 17.0 p75 · 25 sector max 52 10 16th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
KMP1
Selected sub-total2
Procedural
AGM / EGM2
General2
Outcome2
Board Meeting1
Trading Window1
Procedural sub-total8
Total10

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

10 filings · 2 selected · busiest 2026-08-14 and 2026-09-09

Filing rhythm · the twelve most recent

2026-08-042026-10-01

SelectedProcedural

Filings

10 in the window · 1 earlier on record

  1. 1 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer report of 11th Annual genral meeting for 30th September, 2026

    AGM/EGM / AGM View filing →

  2. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings / Outcome of Annual general meeting as on 30th September, 2026

    AGM/EGM / AGM View filing →

  3. 28 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of trading window Quarter ended september, 2026

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 9 September 2026 ·

    General

    Notice Of The Annual General Meeting

    Notice of annual general meeting

    Company Update / General View filing →

  5. 9 September 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of The Baord Meeting

    Outcome of the board meeting

    Others / Outcome without intimation View filing →

  6. 26 August 2026 ·

    Outcome

    Board Meeting Outcome for Appointment Of Mr Janardan Savala As On 26-08-2026 Additional Director In The Capacity Of Executive Director

    Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today i.e . August 26, 2026 which was commenced at 11.00 a.m. and concluded at 1.00 p.m ....

    Others / Outcome without intimation View filing →

  7. 25 August 2026 ·

    KMP

    Cessation

    Resignation of Mr. Ganesh Potdar executive director as on 25-08-2026

    Company Update / Cessation View filing →

  8. 14 August 2026 ·

    General

    Integrated Filing For Quarter Ended June 30, 2026

    Integrated filing for Quarter ended June 30, 2026

    Company Update / General View filing →

  9. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Outcome Of Board Meeting For The Quarter Ended June 30, 2026

    Pursuant to Regulation 29 and 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held ....

    Board Meeting / Outcome of Board Meeting View filing →

  10. 4 August 2026 ·

    Board Meeting

    Board Meeting Intimation for The Quarter Ended June 30,2026

    Lasa Supergenerics Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 ....

    Board Meeting / Board Meeting View filing →

RSS feed for Lasa Supergenerics Ltd · the 50 most recent filings